Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IL › WINFIELD › CENTRAL DUPAGE HOSPITAL ASSOCIATION

CENTRAL DUPAGE HOSPITAL ASSOCIATION

NPI: 1003864810 · WINFIELD, IL 60190 · General Acute Care Hospital · NPI assigned 05/04/2006

$10.62M
Total Medicaid Paid
954,691
Total Claims
762,139
Beneficiaries
302
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHEDLEY, KENNETH (PRESIDENT)
NPI Enumeration Date05/04/2006

Related Entities

Other providers sharing the same authorized official: HEDLEY, KENNETH

ProviderCityStateTotal Paid
CENTRAL DUPAGE HOSPITAL ASSOCIATION WINFIELD IL $30K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 313,222 $3.18M
2019 424,996 $4.72M
2020 182,540 $2.13M
2021 3,976 $17K
2022 5,752 $133K
2023 10,194 $185K
2024 14,011 $255K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 50,973 10,288 $4.61M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 27,677 23,651 $424K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 27,729 23,694 $421K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 15,237 13,243 $339K
97161 4,352 2,802 $319K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2,145 1,735 $313K
84443 Thyroid stimulating hormone (TSH) 43,332 38,335 $271K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 9,257 2,228 $235K
80053 Comprehensive metabolic panel 63,588 55,099 $199K
87799 5,323 3,165 $189K
87481 6,313 3,841 $131K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 74,637 64,044 $112K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2,886 2,481 $110K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 9,052 7,637 $108K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,425 982 $105K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 17,500 15,542 $103K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3,803 2,612 $99K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 9,793 8,546 $98K
0202U Oncology (prostate), multianalyte, gene expression profiling 411 383 $93K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 29,262 25,865 $83K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,580 2,718 $83K
86480 3,575 3,107 $82K
81513 911 854 $77K
97162 1,098 672 $75K
77067 Screening mammography, bilateral, including computer-aided detection 1,319 1,074 $74K
87086 Culture, bacterial; quantitative colony count, urine 20,700 17,925 $69K
80061 Lipid panel 36,653 33,012 $58K
87631 1,115 945 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,856 2,466 $49K
86803 8,306 7,263 $48K
36415 Collection of venous blood by venipuncture 40,938 34,743 $46K
83036 Hemoglobin; glycosylated (A1C) 27,807 25,354 $44K
86769 1,084 543 $41K
87536 1,045 894 $39K
83655 7,531 6,476 $39K
81511 863 774 $38K
87510 5,017 4,477 $38K
87480 5,022 4,481 $37K
87512 3,909 3,039 $33K
84439 15,799 13,899 $32K
86235 1,981 977 $32K
71046 Radiologic examination, chest; 2 views 2,702 1,752 $31K
82607 9,189 8,262 $31K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,114 924 $30K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1,022 726 $30K
87081 14,128 12,613 $29K
83970 2,026 1,810 $28K
86003 13,218 1,946 $28K
84403 2,628 2,274 $27K
87522 Neg quan hep c or qual rna 1,041 960 $27K
87660 4,994 4,448 $26K
94010 797 568 $23K
86038 4,138 3,234 $21K
87581 2,154 1,739 $21K
87486 2,143 1,735 $20K
80081 658 513 $20K
80048 Basic metabolic panel (calcium, ionized) 6,015 5,027 $19K
87186 4,689 3,833 $17K
81001 23,910 20,829 $17K
97165 1,345 720 $16K
87340 6,951 5,862 $16K
84481 5,927 5,172 $15K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,019 586 $15K
83001 2,460 2,110 $14K
86696 1,665 1,221 $14K
80074 1,209 1,038 $14K
86146 560 288 $13K
86592 15,843 13,996 $13K
86787 2,490 1,991 $12K
82746 4,363 3,942 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 696 562 $12K
83516 2,511 1,662 $12K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,885 2,499 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,274 1,140 $12K
87077 4,775 3,417 $11K
84466 4,884 4,315 $11K
87070 5,051 4,269 $11K
82728 5,352 4,722 $10K
87088 2,921 2,575 $10K
85027 6,841 5,931 $10K
84702 3,572 2,775 $9K
84153 2,200 1,972 $9K
84402 1,858 1,619 $9K
86695 1,612 1,184 $8K
82784 1,758 1,175 $8K
86140 6,668 5,287 $8K
82105 1,362 1,261 $8K
82570 6,582 5,858 $8K
87511 541 315 $8K
77063 Screening digital breast tomosynthesis, bilateral 712 566 $8K
86850 6,522 5,348 $8K
84146 2,029 1,747 $8K
83540 5,272 4,655 $7K
83735 4,453 3,712 $7K
82951 1,294 1,176 $7K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 249 127 $7K
86431 3,228 2,532 $7K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 209 203 $6K
86800 1,906 1,638 $6K
86160 1,224 794 $6K
73610 357 189 $6K
86200 2,033 1,540 $6K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 346 158 $6K
86762 4,813 4,127 $6K
86665 461 354 $6K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 863 797 $6K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 286 259 $6K
83520 1,054 635 $6K
82950 4,844 4,369 $6K
86376 2,329 1,999 $6K
85652 8,203 6,652 $6K
86706 1,380 1,112 $5K
86901 6,283 5,183 $5K
82043 5,502 5,010 $5K
86147 694 381 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 632 338 $5K
83525 1,931 1,622 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 194 104 $5K
73630 410 246 $5K
86225 1,430 1,014 $5K
82785 2,037 1,537 $5K
82670 1,700 1,416 $4K
86780 735 625 $4K
90686 244 127 $4K
88184 288 184 $4K
84550 3,581 3,085 $4K
92610 229 145 $4K
80076 1,587 1,394 $4K
82550 2,385 1,828 $4K
85610 3,302 2,311 $4K
86008 89 66 $4K
84480 1,115 980 $4K
86900 6,120 4,990 $4K
87209 659 479 $4K
83002 1,789 1,535 $4K
84144 1,309 1,057 $4K
86141 559 503 $3K
87338 377 340 $3K
83013 923 863 $3K
83021 906 823 $3K
80069 1,456 1,300 $3K
86304 306 265 $3K
87205 3,014 2,432 $3K
84305 737 624 $3K
86704 691 558 $3K
84460 1,744 1,470 $3K
73110 225 129 $3K
87045 733 534 $3K
86361 885 767 $2K
84100 2,141 1,806 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 18 18 $2K
88142 1,124 1,017 $2K
84450 1,614 1,358 $2K
82533 639 543 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 53 31 $2K
86039 772 548 $2K
86359 918 788 $2K
92523 92 43 $2K
83690 1,153 991 $2K
84681 523 464 $2K
88341 36 36 $2K
94664 128 68 $2K
74018 175 130 $2K
86735 608 542 $2K
88304 87 83 $2K
84156 3,004 2,525 $2K
85730 1,210 1,041 $2K
73560 143 75 $2K
82542 305 238 $2K
88342 431 361 $2K
97166 60 37 $2K
82947 1,699 1,470 $2K
86765 868 764 $1K
73130 159 79 $1K
82627 856 732 $1K
80197 331 173 $1K
81374 88 73 $1K
84163 404 381 $1K
84703 617 545 $1K
85007 1,540 1,245 $1K
86334 104 93 $1K
87177 646 470 $1K
83704 131 120 $1K
83880 207 174 $1K
72082 47 28 $1K
84165 457 388 $1K
83615 848 655 $1K
84436 842 771 $1K
87075 192 153 $1K
36416 500 437 $993.72
86060 383 325 $966.09
82150 637 554 $955.02
87563 120 88 $914.29
73140 168 116 $910.79
96040 14 14 $882.81
83090 325 293 $880.51
87046 846 536 $878.16
82652 228 188 $870.64
87906 13 12 $858.67
73030 65 32 $857.34
87521 Neg quan hep c or qual rna 61 56 $851.68
85018 2,169 1,930 $842.81
82274 183 171 $832.42
73564 41 16 $811.95
82565 796 667 $794.00
86747 74 70 $791.59
82952 1,014 946 $766.39
85660 739 601 $765.01
86677 133 99 $754.48
G0008 Administration of influenza virus vaccine 173 109 $753.19
82378 147 134 $744.99
86708 300 246 $729.92
87493 43 29 $728.64
73502 46 26 $719.58
86255 274 251 $673.77
85045 861 682 $629.72
86618 76 68 $626.96
84154 137 129 $602.96
87255 69 54 $573.03
80164 236 216 $566.77
87210 471 371 $560.66
84445 46 40 $547.43
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 27 23 $538.31
88185 341 172 $519.16
87625 67 60 $464.55
82977 425 361 $458.62
86148 146 94 $455.24
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 36 28 $433.99
86308 413 346 $403.84
82248 250 196 $392.84
95012 77 68 $365.64
85014 979 831 $364.31
86593 388 349 $348.78
87184 150 112 $329.36
82672 42 41 $324.64
81025 499 394 $306.75
84446 25 25 $293.48
84238 38 38 $291.80
72100 25 13 $288.98
82575 82 71 $273.33
80051 263 211 $266.58
84520 411 340 $255.13
85732 111 85 $245.00
84590 25 25 $240.35
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 22 21 $238.42
J0696 Injection, ceftriaxone sodium, per 250 mg 147 44 $238.08
85613 107 81 $223.42
82024 47 41 $223.14
81003 322 269 $214.60
83519 49 44 $208.29
86617 13 12 $201.30
86777 100 95 $198.27
71045 Radiologic examination, chest; single view 29 14 $192.78
82164 61 43 $189.75
83498 75 61 $184.14
88312 59 44 $181.57
86645 42 29 $165.14
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 15 12 $165.00
86021 111 95 $152.84
87040 22 19 $145.28
86644 42 29 $143.47
86705 33 26 $135.88
69209 19 14 $122.45
82310 120 102 $121.73
86870 20 12 $114.40
82040 67 55 $105.80
83921 12 12 $105.57
82465 106 103 $104.89
86256 16 13 $104.88
82390 47 42 $99.51
82272 104 100 $95.40
84432 16 12 $90.50
82397 24 16 $81.18
80177 22 14 $79.70
J1885 Injection, ketorolac tromethamine, per 15 mg 80 29 $79.36
85379 40 40 $77.41
82955 37 27 $77.31
86664 24 16 $76.45
81050 88 85 $70.72
86880 32 25 $66.18
82247 48 40 $65.18
82166 16 15 $63.39
84482 16 12 $63.04
83993 15 12 $60.78
80178 33 30 $57.69
82679 31 26 $54.41
82962 222 165 $53.90
84630 15 12 $44.26
80183 12 12 $38.83
84425 12 12 $38.48
83721 17 16 $36.74
81596 13 12 $34.64
84134 15 14 $32.60
82103 14 14 $26.34
84270 12 12 $23.91
J1100 Injection, dexamethasone sodium phosphate, 1 mg 25 12 $22.20
82140 12 12 $17.71
84155 13 12 $8.95
82270 12 12 $7.34
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 49 40 $0.93
90460 Immunization administration through 18 years of age via any route, first or only component 15 15 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 13 13 $0.00